Developmental Neurology Department, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria, 11, 20133, Milan, Italy.
Department of Diagnostic and Technology, Laboratory of Cytogenetic, Unit of Neurological Biochemistry and Neuropharmacology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Cerebellum. 2020 Oct;19(5):629-635. doi: 10.1007/s12311-020-01145-3.
Chromosomal microarray analysis is commonly used as screening test for children with neurodevelopmental issues, also in case of complex neurological phenotypes. Developmental delay/intellectual disability is a common presentation sign in pediatric ataxias, diseases with high clinical and genetic heterogeneity. In order to determine the diagnostic yield of Array-CGH in such conditions, all the tests performed in the last 10-year activity of a single referral center in children who present, besides the neurodevelopmental impairment, cerebellar abnormalities have been systematically gathered. The study demonstrates that, except for Dandy-Walker malformation or poly-malformative phenotypes, chromosomal microarray analysis should be discouraged as first-line diagnostic test in pediatric ataxias with neurodevelopmental disability.
染色体微阵列分析通常被用作神经发育问题儿童的筛查测试,也适用于复杂的神经表型病例。发育迟缓/智力残疾是儿科共济失调的常见表现特征,这些疾病具有高度的临床和遗传异质性。为了确定 Array-CGH 在这些情况下的诊断效果,对在过去 10 年里在单一转诊中心就诊的、除了神经发育障碍外还存在小脑异常的儿童进行了所有检测,系统性地收集了所有这些检测结果。研究表明,除了 Dandy-Walker 畸形或多畸形表型外,对于伴有神经发育障碍的儿科共济失调患者,染色体微阵列分析不应作为一线诊断测试。